RESUMEN
BACKGROUND: Human multipotent mesenchymal stromal cells (hMSCs) produce tumor necrosis factor (TNF)-α-stimulated protein 6 (TSG-6). TSG-6 modulates proinflammatory cytokine cascades and enhances tissue repair. This study tests the effects of recombinant human TSG-6 (rhTSG-6) on gingival wound healing within the first 2 days post-surgery. METHODS: After gingival resection in 120 Sprague-Dawley rats, 2 µg rhTSG-6 in 5-µL phosphate-buffered saline (PBS) or the same volume of only PBS solution was injected into gingival tissue approximating the surgical wound. Control animals did not receive injections. Tissue biopsies and blood were collected at 1 to 2, 6 to 8, 24, and 48 hours post-surgery (n = 10 per group). Specimens were analyzed via histologic analysis and enzyme-linked immunosorbent assay (ELISA) for quantification and comparison of inflammatory markers interleukin (IL)-1ß, IL-6, TNF-α, and myeloperoxidase (MPO). Wound photographs were taken for a double-masked clinical assessment at each time period. Weights were recorded for all animals pre- and post-surgery. RESULTS: Animals injected with rhTSG-6 had significantly less severe clinical inflammation at 6 to 8 (P = 0.01228), 24 (P = 0.01675), and 48 (P = 0.0186) hours. Sham and control animals had more weight loss at 24 and 48 hours. Sham and control animals had more pronounced cellular infiltrate. rhTSG-6-treated animals had significantly less MPO (P = 0.027) at 24 hours and IL-1ß (P = 0.027) at 24 and 48 hours. IL-6 showed a marginal significant difference at 6 to 8 hours, but there was no significant difference for TNF-α. CONCLUSION: rhTSG-6 reduced postoperative gingival inflammation by reducing levels of proinflammatory cytokines and cellular infiltrate and may offer significant promise as an anti-inflammatory agent for gingival surgery.
Asunto(s)
Moléculas de Adhesión Celular/uso terapéutico , Encía/efectos de los fármacos , Gingivectomía/métodos , Factor de Necrosis Tumoral alfa/uso terapéutico , Animales , Antiinflamatorios/uso terapéutico , Peso Corporal , Moléculas de Adhesión Celular/análisis , Eritema/etiología , Eritema/metabolismo , Encía/química , Enfermedades de las Encías/etiología , Enfermedades de las Encías/metabolismo , Hemorragia Gingival/etiología , Hemorragia Gingival/metabolismo , Hipertrofia Gingival/etiología , Hipertrofia Gingival/metabolismo , Gingivitis/etiología , Gingivitis/metabolismo , Humanos , Mediadores de Inflamación/análisis , Interleucina-1beta/análisis , Interleucina-1beta/efectos de los fármacos , Interleucina-6/análisis , Masculino , Peroxidasa/análisis , Peroxidasa/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes , Factores de Tiempo , Factor de Necrosis Tumoral alfa/análisis , Cicatrización de Heridas/efectos de los fármacosRESUMEN
Juvenile hyaline fibromatosis is a rare, hereditary disease with distinct clinical and histopathological features. Clinically, it presents with gingival hypertrophy, pappulonodular skin lesions and joint contractures. Bone involvement is usually an uncommon finding. We report a case of a 2-year-old patient, daughter of consanguineous parents, who presented since the age of 2 months with impairment of mental development, multiple joint contractures, motion limitation and nodules on the scalp. The calvarian lesions were surgically removed, and histopathological examination concluded to juvenile hyaline fibromatosis.
Asunto(s)
Hialina/metabolismo , Síndrome de Fibromatosis Hialina/diagnóstico , Biomarcadores/metabolismo , Biopsia , Encéfalo/metabolismo , Encéfalo/patología , Preescolar , Contractura/diagnóstico , Contractura/etiología , Contractura/metabolismo , Femenino , Hipertrofia Gingival/diagnóstico , Hipertrofia Gingival/etiología , Hipertrofia Gingival/metabolismo , Humanos , Síndrome de Fibromatosis Hialina/complicaciones , Síndrome de Fibromatosis Hialina/metabolismo , Síndrome de Fibromatosis Hialina/patología , Síndrome de Fibromatosis Hialina/cirugía , Imagen por Resonancia Magnética , Valor Predictivo de las Pruebas , Piel/metabolismo , Piel/patologíaRESUMEN
AIM: In the present immunohistochemical study, the expression of vascular endothelial growth factor, nitric oxide synthase 1 and 3, and Ki-67 in the gingival tissues of renal transplant patients treated with cyclosporin A was assessed. Gingival overgrowth (GO) frequently occurs in transplant patients receiving immunosuppressive drugs such as cyclosporine and this gingival inflammation might play an important role in the pathogenesis of drug-induced GO. METHODS: Twenty-eight human gingival biopsies were taken from healthy patients with chronic periodontitis (N.=14 control group), and from renal transplant recipients treated with cyclosporin A (N.=14 test group). The retrieved specimens were immunohistochemically processed and stained for vascular endothelial growth factor, nitric oxide synthase 1 and 3, and Ki-67. RESULTS: The levels of vascular endothelial growth factor, nitric oxide synthase 1 and 3, and Ki-67 were found to be significantly different among groups (P>0.001), with patients treated with cyclosporin A showing higher levels of all the analyzed markers compared to control group. CONCLUSION: In summary, the data from this pilot study suggests that the investigated factors have a role in the inflammation processes associated to immunosuppressive therapy. However, further studies with a larger sample population need to be conducted for an exhaustive knowledge of the mechanisms leading to GO.
Asunto(s)
Ciclosporina/efectos adversos , Hipertrofia Gingival/inducido químicamente , Inmunosupresores/efectos adversos , Antígeno Ki-67/análisis , Trasplante de Riñón , Óxido Nítrico Sintasa de Tipo III/análisis , Óxido Nítrico Sintasa de Tipo II/análisis , Complicaciones Posoperatorias/inducido químicamente , Factor A de Crecimiento Endotelial Vascular/análisis , Adulto , Anciano , Biomarcadores , Biopsia , Ciclosporina/farmacología , Femenino , Encía/irrigación sanguínea , Encía/patología , Hipertrofia Gingival/metabolismo , Hipertrofia Gingival/patología , Humanos , Técnicas para Inmunoenzimas , Inmunosupresores/farmacología , Inflamación , Masculino , Persona de Mediana Edad , Neovascularización Fisiológica , Periodontitis/metabolismo , Complicaciones Posoperatorias/metabolismo , Complicaciones Posoperatorias/patología , Adulto JovenRESUMEN
INTRODUCTION: In the present study, we aimed to assess MMP-9 and type IV collagen in the gingival tissue in patients with gingival overgrowth (GO) after orthodontic treatment, with or without clinical signs of inflammation to appreciate the role of balance between those two markers in the onset of GO during tooth movement. MATERIALS: Gingival tissue was harvested from 45 patients divided in three groups: 15 patients with orthodontic appliance that developed GO on at least two teeth; 15 patients with chronic gingivitis with GO; 15 patients (control group) with healthy periodontal tissues, without clinical gingival changes, in whom the first premolar was planned for extraction for orthodontic purposes (canine distalization). METHODS: The tissue samples obtained by gingivectomy were fixed in 10% neutral formalin solution for 48 hours and then included in paraffin with the usual technique. The histologic examination was performed using classic Hematoxylin-Eosin technique. Double immunofluorescence was performed for anti-MMP-9 and anti-collagen IV antibodies. RESULTS: MMP-9/collagen IV double stainings showed an increase of fibrosis and inflammation in different degrees. CONCLUSIONS: The mechanical stress induced by the orthodontic devices, might be the key players in driving both the inflammation and the fibrotic reaction.
Asunto(s)
Colágeno Tipo IV/metabolismo , Regulación Enzimológica de la Expresión Génica , Hipertrofia Gingival/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Femenino , Encía/metabolismo , Hipertrofia Gingival/patología , Gingivectomía/métodos , Gingivitis/metabolismo , Humanos , Inmunohistoquímica/métodos , Inflamación , Masculino , Microscopía Fluorescente/métodos , OrtodonciaRESUMEN
OBJECTIVES: Cyclosporine A (CsA) is used as an immunosuppressive agent and its prominent side effect is the induction of gingival overgrowth. Type I plasminogen activator inhibitor (PAI-1) has shown to play an important role in CsA-induced gingival overgrowth. However, little is known about whether factors can modulate CsA-induced PAI-1 expression. METHODS: Cytotoxicity, reverse transcriptase-polymerase chain reaction, and enzyme-linked immunosorbent assay were used to investigate the effects of Human gingival fibroblasts (HGFs) exposed to CsA. In addition, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, interlukin-1alpha, tumor necrosis factor-alpha, mitogen-activated protein kinase kinase (MEK) inhibitor U0126, signal-regulated protein kinase (ERK) inhibitor PD98059 and cell-permeable glutathione precursor N-acetyl-L-cysteine (NAC) were added to test how they modulated the effects of CsA-induced PAI-1 expression. RESULTS: The concentration of CsA higher than 500 ng ml(-1) demonstrated cytotoxicity to HGFs (P < 0.05). Periodontal pathogens as well as proinflammatory cytokines were found to increase the CsA-induced PAI-1 mRNA and protein expression (P < 0.05). Pharmacological agents NAC, U0126, and PD98059 were found to decrease the CsA-induced PAI-1 mRNA and protein expression (P < 0.05). CONCLUSIONS: Cyclosporine A (CsA) may predispose to gingival overgrowth under inflammatory environments. The regulation of PAI-1 expression induced by CsA might be critically related with the intracellular glutathione and the ERK-MAPK pathway.
Asunto(s)
Ciclosporina/farmacología , Fibroblastos/efectos de los fármacos , Encía/efectos de los fármacos , Hipertrofia Gingival/prevención & control , Inmunosupresores/farmacología , Inhibidor 1 de Activador Plasminogénico/metabolismo , Células Cultivadas , Ciclosporina/efectos adversos , Relación Dosis-Respuesta a Droga , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Fibroblastos/citología , Fibroblastos/metabolismo , Encía/citología , Encía/metabolismo , Hipertrofia Gingival/inducido químicamente , Hipertrofia Gingival/metabolismo , Humanos , Inmunosupresores/efectos adversos , Inhibidor 1 de Activador Plasminogénico/genética , ARN Mensajero/análisisRESUMEN
UNLABELLED: Gingival overgrowth occurs as a response to several drugs, in some systemic diseases, as a consequence of a genetic predisposition or could be idiopathic, the last being less studied. Independently of the etiological factor involved, histological changes are maintained and intensified by the presence of the bacterial plaque. MATERIAL AND METHODS: Fibrotic mucosa clinically diagnosed with idiopathic hypertrophy was included in paraffin and studied using usual histological stains and immunohistochemical techniques for vimentin, MMP-3 and TIMP-2. RESULTS: Evaluation of histological changes revealed an unspecific pattern like the thickening of the epithelium, with acanthosis and acantholysis and massive deposition of connective tissue in the lamina propria. Keratinocytes from the areas with acantholysis express MMP-3. In the fibrous areas we noted few fibroblasts and a discrete expression of MMP-3. Extended areas of inflammatory tissue with numerous de novo capillaries were observed among the collagen bundles. Proinflammatory and endothelial cells expressed both MMP-3 and TIMP-2. The last antibody had an intense expression deeper in the epithelium. Our results were discussed in accordance with reference data. CONCLUSIONS: We conclude that the histological changes observed were not specific for the idiopathic gingival hypertrophy and the imbalance of tissue homeostasis was due to the interaction between keratinocytes and connective cells in the milieu of specific changes induced by the inflammatory conditions.
Asunto(s)
Hipertrofia Gingival/enzimología , Hipertrofia Gingival/patología , Adolescente , Adulto , Biomarcadores/metabolismo , Tejido Conectivo/metabolismo , Citocinas/metabolismo , Femenino , Fibroblastos/metabolismo , Hipertrofia Gingival/etiología , Hipertrofia Gingival/metabolismo , Humanos , Inmunohistoquímica , Queratinocitos/metabolismo , Masculino , Metaloproteinasa 2 de la Matriz/biosíntesis , Metaloproteinasa 3 de la Matriz/biosíntesis , Persona de Mediana Edad , Inhibidor Tisular de Metaloproteinasa-2/metabolismo , Inhibidor Tisular de Metaloproteinasa-3/metabolismo , Vimentina/metabolismoRESUMEN
Hyalinosis cutis et mucosae (lipoid proteinosis, Urbach-Wiethe disease) is a rare syndrome with autosomal recessive inheritance. The disease is characterized by diffuse deposition of a hyalinelike substance in the dermis, submucosal connective tissue, and various internal organs. In this study, the patient demonstrated classic signs and symptoms of lipoid proteinosis except for gingival infiltration. Gingival infiltration is still an unexplainable feature of this disease. In the context of this case, the diagnostic significance of the microscopic findings of the gingival tissues and the possible factors playing a role in gingival hypertrophy, are discussed.
Asunto(s)
Hipertrofia Gingival/etiología , Proteinosis Lipoidea de Urbach y Wiethe/patología , Adulto , Hipertrofia Gingival/metabolismo , Humanos , Hialina/metabolismo , Proteinosis Lipoidea de Urbach y Wiethe/complicaciones , Proteinosis Lipoidea de Urbach y Wiethe/metabolismo , Masculino , SíndromeRESUMEN
Cyclosporine is now the elective drug for immunosuppressive treatment in organ transplant patients. Compared to traditional immunosuppressants this molecule offers the therapeutic advantage that it does not act indiscriminately on all components of the immune system. In addition to the primary pharmacological action, cyclosporine also presents a number of undesirable effects, among which it is worth mentioning short and long-term nephrotoxicity and the development of neoplasia, in particular lymphomas. Other undesired effects of the drug are the possibility of overinfection, thrombosis, hypertension, hypertrichosis, hepatotoxicity and the development of the hypertrophic and hyperplastic gingival pathology.
Asunto(s)
Ciclosporina/efectos adversos , Hipertrofia Gingival/inducido químicamente , Inmunosupresores/efectos adversos , Colágeno/efectos de los fármacos , Colágeno/metabolismo , Encía/efectos de los fármacos , Encía/metabolismo , Hipertrofia Gingival/diagnóstico , Hipertrofia Gingival/metabolismo , Hipertrofia Gingival/patología , HumanosRESUMEN
The mechanisms of denture-induced gingival hypertrophy remain to be explored. Since fibroblast proliferation and bone resorption characterize this disorder, the possible involvement of cytokines was investigated. Gingival fibroblasts were obtained from six patients with denture fibromatosis (Den-Fb) and six healthy persons (Nor-Fb). Cells were compared for proliferation, collagen synthesis, and cytokine production. Incorporation of [3H]thymidine (TdR) was increased in 3 Den-Fb and 3 Nor-Fb lines in the presence of interleukin-1-beta (IL-1 beta) (10 U/mL) and tumor necrosis factor-alpha (TNF-alpha) (from 10 to 100 U/mL). Proline incorporation in Den-Fb was higher than that in Nor-Fb, and the mean collagen synthesis level in Den-Fb was significantly higher than that in Nor-Fb. Although there was no difference between the up-regulation of protein synthesis in Den-Fb and Nor-Fb induced by IL-1 beta or TNF-alpha, the receptors for these cytokines were expressed at higher levels in cell lines which exhibited higher protein synthesis. Between Nor-Fb and Den-Fb, there was no difference in the generation of granulocyte-macrophage colony-stimulating factor (GM-CSF) or interleukin-6 (IL-6). However, most Den-Fb produced more GM-CSF and IL-6 in the presence of TNF-alpha. Enhancement of IL-6 generation by GM-CSF was also more prominent in Den-Fb. GM-CSF and IL-6 were synergistically generated after co-culture of the fibroblasts with gingival keratinocytes. GM-CSF and IL-6 generation of Den-Fb was markedly enhanced by co-culture of Den-Fb with peripheral blood mononuclear cells (PBMC), especially PBMC from patients.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Colágeno/biosíntesis , Citocinas/biosíntesis , Fibromatosis Gingival/metabolismo , Estomatitis Subprotética/complicaciones , Anciano , Pérdida de Hueso Alveolar/etiología , Pérdida de Hueso Alveolar/metabolismo , Estudios de Casos y Controles , Células Cultivadas , Citocinas/fisiología , Dentaduras/efectos adversos , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Fibromatosis Gingival/etiología , Hiperplasia Gingival/etiología , Hiperplasia Gingival/metabolismo , Hipertrofia Gingival/etiología , Hipertrofia Gingival/metabolismo , Factor Estimulante de Colonias de Granulocitos y Macrófagos/biosíntesis , Humanos , Interleucina-1/fisiología , Interleucina-6/biosíntesis , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Leucocitos Mononucleares/fisiología , Persona de Mediana Edad , Proteínas Recombinantes/farmacología , Estadísticas no Paramétricas , Estomatitis Subprotética/metabolismo , Factor de Necrosis Tumoral alfa/fisiología , Regulación hacia ArribaRESUMEN
Fibroblasts from nifedipine-induced fibrotic gingiva (NFG) have been characterized with respect to several cellular functions which could contribute to the characteristic clinical overgrowth of the gingiva: collagen synthesis and breakdown, glycosaminoglycan production, fibronectin synthesis, and proliferation. Histologic examination of NFG tissue revealed a hyperplastic epithelium with elongated, branched rete pegs. The connective tissue consisted of densely-packed collagen fibers and numerous enlarged fibroblasts, as well as regions of thinner, disorganized collagen fibers in the vicinity of scattered inflammatory and mast cells. Results of in vitro experiments showed that the fibroblast strains from the fibrotic gingiva (NFG) produced significantly greater amounts of collagen and lower levels of collagenase activity when compared to age- and sex-matched normal human gingival fibroblast strains. The NFG fibroblasts did not produce significantly greater amounts of fibronectin, and their level of glycosaminoglycan production was less than that of the normal fibroblasts. The NFG fibroblasts did not proliferate significantly more rapidly than the normal fibroblast strains. These findings therefore show that there are defects in the regulation of collagen production by NFG fibroblasts in vitro, and suggest that these alterations in collagen metabolism contribute to the over-deposition of collagen in this tissue, rather than hyperproliferation of the fibroblasts or through the production of increased amounts of fibronectin and glycosaminoglycans.
Asunto(s)
Colágeno/biosíntesis , Hipertrofia Gingival/inducido químicamente , Hipertrofia Gingival/metabolismo , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática , Femenino , Fibroblastos/metabolismo , Fibronectinas/biosíntesis , Glicosaminoglicanos/biosíntesis , Humanos , Masculino , Nifedipino/efectos adversosRESUMEN
The present study investigates the relationship between the pharmacokinetic variables of nifedipine with the incidence and severity of gingival overgrowth in 9 adult male patients medicated with the drug for at least 6 months. Five of the patients had experienced significant gingival changes and were thus designated "responders". The remaining four patients exhibited no gingival overgrowth, and thus acted as a control. A baseline periodontal examination (plaque scores, bleeding index and gingival overgrowth assessment) was carried out on each patient, and confined to the upper and lower anterior teeth. Serial blood and gingival crevicular fluid samples were collected over an eight-hour investigation period. Samples were analyzed for nifedipine by gas chromatography. No significant difference (p > 0.05) was seen between responders and non-responders with regard to drug therapy, periodontal parameters or plasma pharmacokinetics of nifedipine. Nifedipine was detected in the gingival crevicular fluid of seven subjects (all responders, and two non-responders). The peak concentration of nifedipine in crevicular fluid was 15-90 fold greater than levels observed in plasma.
Asunto(s)
Líquido del Surco Gingival/metabolismo , Hipertrofia Gingival/inducido químicamente , Nifedipino/efectos adversos , Adulto , Anciano , Distribución de Chi-Cuadrado , Líquido del Surco Gingival/química , Hipertrofia Gingival/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Nifedipino/análisis , Nifedipino/sangre , Nifedipino/farmacocinéticaRESUMEN
Three cases of gingival overgrowth induced by cyclosporin and/or nifedipine have been reported. Patient A was under medication with cyclosporin plus nifedipine, patient B with nifedipine only and patient C with cyclosporin only. The significance of androgen metabolism in gingival tissue with respect to hyperplastic changes has been studied by several workers. Hence, we have investigated whether gingival tissue from the above patients showed significant metabolism of the androgen, testosterone, to its biologically-active form, 5 alpha-dihydrotestosterone (5 alpha-DHT). Radical gingivectomy was carried out in all 3 cases to remove the hyperplastic tissue. The excised tissue was incubated with labelled testosterone in order to study the extent of androgen metabolism. Healthy gingivae from males and females produced 5 alpha-DHT (22.4 +/- 7.7, s.e.m., n = 8). Very significantly higher values (p less than 0.001) were recorded for patients A, B and C (1139, 542 and 994 fmol/mg, respectively). These represented increases of 51-, 24- and 44.4-fold, respectively over control values. Corresponding production of 4-androstenedione from testosterone was 28 +/- 8.3, s.e.m., n = 8, fmol/mg. In patients A, B and C, 4-androstenedione production was elevated: 85, 901 and 113 fmol/mg, respectively, representing increases of 3-, 32- and 4-fold. Even the lower values of 85 and 113 fmol/mg were very highly significant (p less than 0.001) compared with control values. Although healthy female gingival tissue does not metabolize testosterone significantly, in the presence of inflammation the extent of 5 alpha-DHT formation is comparable to that of male samples.(ABSTRACT TRUNCATED AT 250 WORDS)